Augmedix, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Augmedix, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Augmedix, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$8.73M, a 76.8% decline year-over-year.
  • Augmedix, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$23.9M, a 14.1% decline year-over-year.
  • Augmedix, Inc. annual Operating Income (Loss) for 2023 was -$18.8M, a 16.1% increase from 2022.
  • Augmedix, Inc. annual Operating Income (Loss) for 2022 was -$22.4M, a 27.5% decline from 2021.
  • Augmedix, Inc. annual Operating Income (Loss) for 2021 was -$17.6M, a 28.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$18.8M +$3.59M +16.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 -$22.4M -$4.82M -27.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 -$17.6M -$3.86M -28.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 -$13.7M +$3.05M +18.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$16.7M Jan 1, 2019 Dec 31, 2019 10-K/A 2021-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.